Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Invested Capital: 2024-2025

Historic Invested Capital for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $246.9 million.

  • Kura Oncology's Invested Capital fell 41.98% to $246.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $246.9 million, marking a year-over-year decrease of 41.98%. This contributed to the annual value of $416.2 million for FY2024, which is N/A change from last year.
  • Per Kura Oncology's latest filing, its Invested Capital stood at $246.9 million for Q3 2025, which was down 20.00% from $308.6 million recorded in Q2 2025.
  • Kura Oncology's 5-year Invested Capital high stood at $505.1 million for Q1 2024, and its period low was $246.9 million during Q3 2025.